Autologous iPSC-Derived Dopamine Neuron(National Institute of Neurological Disorders & Stroke)(Autologous iPSC-Derived Dopamine Neuron(National Institute of Neurological Disorders & Stroke))

概要

基本信息

药物类型

细胞疗法

别名-

靶点-

作用方式-

作用机制

细胞替代物

治疗领域

神经系统疾病内分泌与代谢疾病

在研适应症

帕金森病

非在研适应症-

原研机构

National Institute of Neurological Disorders & Stroke

在研机构

McLean Hospital, Inc.

非在研机构-

权益机构-

最高研发阶段临床1期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

1

项与 Autologous iPSC-Derived Dopamine Neuron(National Institute of Neurological Disorders & Stroke) 相关的临床试验

NCT06422208

/ Enrolling by invitation临床1期IIT

A Phase 1 Clinical Trial of Autologous iPSC-Derived Dopamine Neuron Transplantation for Parkinson's Disease

This research study is evaluating an investigational cell product called autologous induced pluripotent stem cell (iPSC)-derived dopamine neurons. This research study is a single-center Phase 1 clinical trial, which will test the safety of injecting the investigational cell product into the brain of subjects with Parkinson's disease.

开始日期2024-08-07

申办/合作机构

McLean Hospital, Inc.

[+1]

100 项与 Autologous iPSC-Derived Dopamine Neuron(National Institute of Neurological Disorders & Stroke) 相关的临床结果

登录后查看更多信息

100 项与 Autologous iPSC-Derived Dopamine Neuron(National Institute of Neurological Disorders & Stroke) 相关的转化医学

登录后查看更多信息

100 项与 Autologous iPSC-Derived Dopamine Neuron(National Institute of Neurological Disorders & Stroke) 相关的专利（医药）

登录后查看更多信息

100 项与 Autologous iPSC-Derived Dopamine Neuron(National Institute of Neurological Disorders & Stroke) 相关的药物交易

登录后查看更多信息